Here are the caveats to the 41% decrease in Long Covid associated with Metformin.

Here are the caveats to the 41% decrease in Long Covid associated with Metformin.

A recent clinical trial published in The Lancet Infectious Diseases has shown promising results for using metformin as a potential treatment for preventing long Covid. The trial, named COVID-OUT, aimed to investigate whether taking metformin during the acute phase of a SARS-CoV-2 infection could reduce the risk of long Covid development. The trial was conducted …

Read more